Atossa Therapeutics (NASDAQ: ATOS) deepens Z-endoxifen bet as 2025 losses widen and rare disease optionality grows
Read More 2 minute read Technology Industry News Infosys to help Global Express in tech separation from Toll Holdings Infosys said that it has been engaged by Global Express, an Australian express logistics business, to separate the… byPallavi MadhirajuJune 29, 2022